Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03166085
Title PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

Her2-receptor negative breast cancer

Therapies

Nab-paclitaxel + PU-H71

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.